APA (7th ed.) Citation

Ahmed Bagit, B., Khalad Maliyar, M., Jorge R. Georgakopoulos, M., Brian Rankin, B., Alexander Rimke, M., Asfandyar Mufti, M., . . . Jensen Yeung, M. (2023). Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor class. Elsevier.

Chicago Style (17th ed.) Citation

Ahmed Bagit, BSc, et al. Real-world Effectiveness and Safety of Risankizumab in Patients with Plaque Psoriasis in Whom Guselkumab Failed Recently: A Multicenter Retrospective Study of Switching Within the Interleukin-23 Inhibitor Class. Elsevier, 2023.

MLA (9th ed.) Citation

Ahmed Bagit, BSc, et al. Real-world Effectiveness and Safety of Risankizumab in Patients with Plaque Psoriasis in Whom Guselkumab Failed Recently: A Multicenter Retrospective Study of Switching Within the Interleukin-23 Inhibitor Class. Elsevier, 2023.